Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family
Molecular Genetics & Genomic Medicine · 2025
DOI: 10.1002/mgg3.70081 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Samira Kalayinia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran. Hauptthemen laut MEDLINE: Intellectual Disability, Cerebellar Ataxia, Adenosine Triphosphatases. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cerebellar ataxia, mental retardation, and dysequilibrium (CAMRQ) syndrome is a rare neurodevelopmental disorder characterized by non‐progressive cerebellar ataxia, intellectual disability, and cerebellar atrophy. Despite its rarity, CAMRQ syndrome poses significant challenges due to its heterogeneous genetic etiology and complex clinical presentation. This study details the evolving clinical phenotype over 7 years in a male with CAMRQ4 syndrome caused by an in‐frame deletion variant in ATP8A2 gene.
Methods
A detailed clinical evaluation was performed, accompanied by tests and imaging studies. Clinical and genetic investigations, including segregation analysis, were carried out to confirm the pathogenicity of the identified variant. The evolving clinical phenotype of the patient, including developmental delay, cerebellar ataxia, and hand‐foot crawling, was thoroughly investigated.
Results
A 10‐year‐old male patient with CAMRQ syndrome exhibited typical clinical manifestations including impaired motor coordination, cognitive impairment, and balance disturbances. Genetic analysis revealed a homozygous in‐frame deletion variant (c.1286_1288delAGA) in the ATP8A2 gene, implicating ATP8A2 in the pathogenesis of CAMRQ syndrome. This variant was predicted to be likely pathogenic and deleterious, in accordance with its segregation in affected family members. Our findings expand the mutational spectrum of ATP8A2‐associated CAMRQ syndrome and underscore the importance of comprehensive genetic testing in diagnosing rare neurological disorders.
Conclusion
The identification of an in‐frame deletion variant in the ATP8A2 gene enhances our understanding of CAMRQ syndrome and highlights the phenotypic variability of the disorder. Our study contributes to the elucidation of CAMRQ syndrome by identifying a novel genetic variant and elucidating its clinical and genetic implications. Further research is warranted to advance our understanding of CAMRQ syndrome and to improve patient care and management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
- Rajaie Cardiovascular Institute, Tehran, Iran.
- Children's Medical Centre, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Prosthodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Pediatric Neurology Department, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
- Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Samira Kalayinia, Zahra Rezaei, Nejat Mahdieh
Zitieren
APA
Kalayinia, S., Hesami, H., Badv, R. S., Rabbani, M., Rezaei, Z., Hosseinkhani, Z., Nikbakht, S., Sharifi, A., Akbari, B., Mirab Samiee, S., & Mahdieh, N. (2025). Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70081
Vancouver
Kalayinia S, Hesami H, Badv RS, Rabbani M, Rezaei Z, Hosseinkhani Z, et al. Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70081
BibTeX
@article{Kalayinia2025,
author = {Kalayinia, Samira and Hesami, Hamed and Badv, Reza Shervin and Rabbani, Maryam and Rezaei, Zahra and Hosseinkhani, Zohreh and Nikbakht, Sedighe and Sharifi, Ameneh and Akbari, Bahman and Mirab Samiee, Siamak and Mahdieh, Nejat},
title = {Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7‐Year Follow‐Up With Clinical, Genetic, and ACMG Insights in an Iranian Family},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
doi = {10.1002/mgg3.70081}
}
EUVIMED